Mass Spectrometry in Cancer Biomarker Research: A Case for Immunodepletion of Abundant Blood-Derived Proteins from Clinical Tissue Specimens

Authors:

Abstract
The discovery of clinically relevant cancer biomarkers using mass spectrometry (MS)-based proteomics has proven difficult, primarily because of the enormous dynamic range of blood-derived protein c...
Funding Information
  • National Cancer Institute

This publication has 84 references indexed in Scilit: